S-phase fraction in superficial urothelial carcinoma of the bladder: A prospective, long-term, follow-up study

Scandinavian Journal of Urology and Nephrology

Volumn 38, Issue 4, 2004, Pages 278-284

  Falkman, Karin ^a   Tribukait, Bernhard ^b   Nyman, Claes R ^a   Larsson, Per ^c   Norming, Ulf ^a  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bladder neoplasms; Cell proliferation; Flow cytometry; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE; DOXORUBICIN; MITOMYCIN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE S PHASE; CYSTECTOMY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; TRANSURETHRAL RESECTION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PLOIDIES; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; S PHASE; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 4644228226     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365590410031760     Document Type: Article

References (28)

1. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, et al. Superficial bladder cancer: progression and recurrence. J Urol 1983; 130: 1083-6.
2. Kurth KH, Denis L, Bouffioux CH, et al. Factors affecting recurrence and progression in superficial bladder tumors. Eur J Cancer 1995; 31A: 1840-6.
3. Larsson P, Wijkstrom H, Thorstenson A, Adolfsson J, Norming U, Wiklund P, et al. A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years. Scand J Urol Nephrol 2003; 37: 195-201.
4. Zieger K, Wolf H, Olsen PR, et al. Long term survival of patients with bladder tumors: the significance of risk factors. Br J Urol 1998; 82: 667-72.
5. Neulander E, Kaneti J, Chaimovitz C, et al. Deoxy-ribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer. J Urol 1997; 157: 1254-9.
6. Blomjous ECM, Schipper NW, Baak JP, et al. The value of morphometry and DNA flow cytometry in addition to classic prognosticators in superficial urinary bladder carcinomas. Am J Clin Pathol 1989; 91: 243-8.
7. Tribukait B. Flow cytometry in assessing the clinical aggressiveness of genitourinary neoplasm. World J Urol 1987; 5: 108-22.
8. Wheeless LL, Badalament RA, deVere White R, et al. Consensus review of the clinical utility of DNA cytometry in bladder cancer. Cytometry 1993; 14: 478-81.
9. Harmer MH. Classification of malignant tumors, 3rd ed. Geneva, Switzerland: UICC; 1978. p. 113-7.
10. Mostofi KF, Sobin LH, Torloni H. Histological typing of urinary bladder tumors. In: International histological classification of tumors, No. 10. Geneva, Switzerland: WHO; 1973.
11. Baisch H, Gödhe W, Linden WA. Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle. Radiat Environ Biophys 1975; 12: 31-9.
12. Allard P, Fradet PB, Têtu B. The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index. Br J Urol 1998; 81: 692-8.
13. Masters JRW, Camplejohn RS, Parkinson MC, et al. DNA ploidy and the prognosis of stage pT1 bladder cancer. Br J Urol 1989; 64: 403-8.
14. deVere White R, Deitch A, Daneshmand S, et al. The prognostic significance of S-phase analysis in stage Ta/T1 bladder cancer. Eur Urol 2000; 37: 595-600.
15. Strang P, Stendahl U, Tribukait B. Prognostic significance of S-phase fraction as measured by DNA flow cytometry in gynecologic malignancies. Ann N Y Acad Sci 1993; 677: 354-63.
16. Pfister C, Lacombe L, Vezina M, et al. Prognostic value of the proliferative index determined by Ki67 immunostaining in superficial bladder tumors. Hum Pathol 1999; 30: 1350-5.
17. Lipponen PK, Eskelinen MJ, Jauhiainen K, et al. Proliferation indices as independent prognostic factors in papillary Ta-T1 transitional cell bladder tumors. Br J Urol 1993; 72: 451-7.
18. Tachibana M, Miyakawa A, Miyakawa M, et al. Prognostic significance of flow cytometric deoxyribonucleic acid analysis for patients with superficial bladder cancers: a long-term follow-up study. Cancer Detect Prev 1999; 23: 155-62.
19. Asakura T, Takano Y, Iki M, et al. Prognostic value of Ki-67 for recurrence and progression of superficial bladder cancer. J Urol 1997; 158: 385-8.
20. Liukkonen T, Rajala P, Raitanen M, Rintala E, Kaasinen E, Lipponen P. Prognostic value of MIB-1 score, p53, EGFr, mitotic index, and papillary status in primary superficial (stage pTa/T1) bladder cancer: a prospective comparative study. The Finnbladder Group. Eur Urol 1999; 36: 393-400.
21. Blanchet P, Droupy S, Eschwege P, et al. Prospective evaluation of Ki67 labeling in predicting the recurrence and progression of superficial bladder transitional cell carcinoma. Eur Urol 2001; 40: 169-75.
22. Oosterhuis W, Schapers R, Janssen-Heijnen M, et al. MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder. Cancer 2000; 88: 1598-605.
23. Grossman HB, Liebert M, Antelo M, et al. P53 and Rb expression predict progression in T1 bladder cancer. Clin Cancer Res 1998; 4: 829-34.
24. Bol M, Baak J, Rep S, et al. Prognostic value of proliferative activity and nuclear morphometry for progression in TaT1 urothelial carcinomas of the urinary bladder. Urology 2002; 60: 1124-30.
25. Kiemeney LALM, Witjes JA, Heijbroek RP, et al. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J Urol 1993; 150: 60-4.
26. Kaubisch S, Lum B, Reese J, et al. Stage T1 bladder cancer: grade is the primary determinant for risk of muscle invasion. J Urol 1991; 146: 28-31.
27. Mostofi FK, Davies CJ, Sesterhenn IA. Histological typing of urinary bladder tumors. In: International classification of tumors, No. 10, 2nd ed. Geneva, Switzerland: WHO; 1999.
28. Bergkvist A, Ljungqvist A, Moberger G. Classification of bladder tumors based on the cellular pattern. Preliminary report of a clinico-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 1965; 130: 371-8.